Stockreport

Bio-Techne expands diagnostic portfolio with acquisition of Asuragen for $320M [Seeking Alpha]

Bio-Techne Corp  (TECH) 
Last bio-techne corp earnings: 4/30 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.bio-techne.com
PDF Bio-Techne expands diagnostic portfolio with acquisition of Asuragen for $320M [Read more]